Transplantation and Cellular Therapy 2022: Results of a real world study examining CAR-T therapy brexucabtagene autoleucel for treatment of relapsed mantle cell lymphoma.
Home / Resource Library / Real World Early Outcomes With Brexu-Cel in MCL Demonstrate Feasibility and Positive Efficacy